Deal Details

Certara Completes $310 Million Follow-On Offering

Healthcare

Certara follow-on offering

Summary

Certara, Inc. (“Certara”) (NASDAQ:CERT) recently completed an underwritten public offering of 10,000,000 shares of its common stock by certain existing stockholders, including EQT AB, at a price to the public of $31.00 per share, for total gross proceeds of $310.0 million. Certara did not receive any proceeds from the sale of shares in the offering by the selling stockholders.

Baird served as a bookrunner on this offering.

About

Certara accelerates medicines using proprietary biosimulation software and technology to transform traditional drug discovery and development. Certara’s clients include 1,650 global biopharmaceutical companies, leading academic institutions and key regulatory agencies across 61 countries. Certara, Inc. is headquartered in Princeton, New Jersey.

EQT AB is a purpose-driven global investment organization with more than €71 billion in assets under management across 27 active funds. EQT funds have portfolio companies in Europe, Asia-Pacific and the Americas with total sales of approximately €29 billion and more than 175,000 employees. EQT works with portfolio companies to achieve sustainable growth, operational excellence and market leadership. EQT AB is headquartered in Stockholm, Sweden.

Healthcare

Certara follow-on offering